speb/financial-data huggingface dataset:
Financial ratios for BELFA — quarterly report dated 2025-03-31
Total revenue: 152238000
Gross profit: 58819000
Operating income: 22090000
Net income: 18322000
Capital expenditures: 2732000
Operating cash flow: 8147000
Depreciation & amortization: 6684000
Net tangible assets: -59537000
Owner earnings: 22274000
Return on net tangible assets (%): -37.41202949426407
Capex to operating income (%): 12.36758714350385
Buffett classification: The Great
Stock price: 71.87
P/E ratio: 2.0743362052450607
Shares outstanding: 2115263
Book value: 457935000
P/B ratio: 0.3319771404456965
Market cap (USD): 152023951.81
Debt to equity: 0.6788823741360673
Current ratio: 3.312131972850272
Quick ratio: 1.8304490493100194
Effective tax rate (%): 22.968257305024174
Interest coverage ratio: 5.320327552986512
COGS to revenue (%): 61.36378565141424
R&D to revenue (%): 4.743887859798473
SG&A to revenue (%): 19.38215163099883
Free cash flow (dilution-adjusted): 4178000
Buyback yield (%): 0
Retained earnings: 362041000
Inventory turnover: 0.5668112732457604
Receivables turnover: 1.3936486721532082
Capitalized R&D asset: 7222000
ROCI (R&D-adjusted, %): 3.2165570955422744
FCF margin (%): 2.7443870781276685
Rule of 40 score: 2.7443870781276685
Financial ratios for BELFA — quarterly report dated 2025-06-30
Total revenue: 168299000
Gross profit: 65083000
Operating income: 26065000
Net income: 26861000
Capital expenditures: 881000
Operating cash flow: 20717000
Depreciation & amortization: 6600000
Net tangible assets: -31549000
Owner earnings: 32580000
Return on net tangible assets (%): -103.26793242258074
Capex to operating income (%): 3.3800115096873204
Buffett classification: The Great
Stock price: 89.69
P/E ratio: 4.1988787479804355
Shares outstanding: 2115263
Book value: 485709000
P/B ratio: 0.390600006320657
Market cap (USD): 189717938.47
Debt to equity: 0.5730715304843024
Current ratio: 3.051328959881369
Quick ratio: 1.7243999935526506
Effective tax rate (%): 20.49318970889344
Interest coverage ratio: 6.527673428499875
COGS to revenue (%): 61.32894431933642
R&D to revenue (%): 4.8152395439069755
SG&A to revenue (%): 18.36849892156222
Free cash flow (dilution-adjusted): 15068000
Buyback yield (%): 0
Retained earnings: 388035000
Inventory turnover: 0.6268888780914436
Receivables turnover: 1.3185959963959728
Capitalized R&D asset: 12942740
ROCI (R&D-adjusted, %): 3.461868354558695
Rosenberg metric: 0.8673497646081418
FCF margin (%): 8.953113209228814
Revenue growth (%): 10.549928401581733
Rule of 40 score: 19.50304161081055
Financial ratios for BELFA — quarterly report dated 2025-09-30
Total revenue: 178980000
Gross profit: 71140000
Operating income: 30787000
Net income: 22555000
Capital expenditures: 1036000
Operating cash flow: 22180000
Depreciation & amortization: 6652000
Net tangible assets: -8095000
Owner earnings: 28171000
Return on net tangible assets (%): -348.0049413218036
Capex to operating income (%): 3.3650566797674344
Buffett classification: The Great
Stock price: 116.22
P/E ratio: 3.629216479081166
Shares outstanding: 2115263
Book value: 509031000
P/B ratio: 0.4829487120823683
Market cap (USD): 245835865.85999998
Debt to equity: 0.49006249128245627
Current ratio: 3.0584253707794256
Quick ratio: 1.7479804354686022
Effective tax rate (%): 19.455058386601433
Interest coverage ratio: 8.481267217630855
COGS to revenue (%): 60.252542183484195
R&D to revenue (%): 4.217789697172869
SG&A to revenue (%): 18.328304838529444
Free cash flow (dilution-adjusted): 18559000
Buyback yield (%): 0
Retained earnings: 409417000
Inventory turnover: 0.6492005393951069
Receivables turnover: 1.3248160594531377
Capitalized R&D asset: 15361940
ROCI (R&D-adjusted, %): 3.649962347544159
Rosenberg metric: 0.7474086870681145
FCF margin (%): 10.369315007263381
Revenue growth (%): 6.346442937866535
Rule of 40 score: 16.715757945129916
Financial ratios for BELFA — annual report dated 2025-12-31
Total revenue: 675455000
Gross profit: 264418000
Operating income: 107723000
Net income: 74111000
Capital expenditures: 4198000
Operating cash flow: 80612000
Depreciation & amortization: 26592000
Net tangible assets: -7274000
Owner earnings: 96505000
Return on net tangible assets (%): -1326.711575474292
Capex to operating income (%): 3.8970322029650126
Buffett classification: The Great
Stock price: 151.71
P/E ratio: 4.330079876536547
Shares outstanding: 2115263
Book value: 518674000
P/B ratio: 0.6187056797333199
Market cap (USD): 320906549.73
Debt to equity: 0.42685000597677925
Current ratio: 3.0190356624426222
Quick ratio: 1.7065479226332927
Effective tax rate (%): 22.029458179905312
Interest coverage ratio: 7.3027591349739005
COGS to revenue (%): 60.85335070434004
R&D to revenue (%): 4.569808499455922
SG&A to revenue (%): 18.628628109940706
Free cash flow (dilution-adjusted): 61797000
Buyback yield (%): 0
Retained earnings: 403102000
Inventory turnover: 2.4573264781491004
Receivables turnover: 5.146833591136646
Capitalized R&D asset: 54090330
ROCI (R&D-adjusted, %): 13.10482628400775
Rosenberg metric: 2.6312219113033155
FCF margin (%): 9.148944045125138
Revenue growth (%): 26.302375502999297
Rule of 40 score: 35.45131954812443
Financial ratios for BELFA — quarterly report dated 2025-12-31
Total revenue: 175938000
Gross profit: 69376000
Operating income: 28781000
Net income: 6441000
Capital expenditures: 3383000
Operating cash flow: 29568000
Depreciation & amortization: 6656000
Net tangible assets: -7274000
Owner earnings: 9714000
Return on net tangible assets (%): -133.544129777289
Capex to operating income (%): 11.754282339043119
Buffett classification: The Great
Stock price: 151.71
P/E ratio: 4.326110485851792
Shares outstanding: 2115263
Book value: 518674000
P/B ratio: 0.6187056797333199
Market cap (USD): 320906549.73
Debt to equity: 0.42685000597677925
Current ratio: 3.0190356624426222
Quick ratio: 1.7065479226332927
Effective tax rate (%): 32.646658998222314
Interest coverage ratio: 9.67103494623656
COGS to revenue (%): 60.56792733803954
R&D to revenue (%): 4.542509293046415
SG&A to revenue (%): 18.530959769918947
Free cash flow (dilution-adjusted): 23992000
Buyback yield (%): 0
Retained earnings: 403102000
Inventory turnover: 0.6370658217253542
Receivables turnover: 1.34061278450437
Capitalized R&D asset: 15724150
ROCI (R&D-adjusted, %): 3.5084474614000043
Rosenberg metric: -0.2336733342164525
FCF margin (%): 13.636621991838032
Revenue growth (%): -1.6996312437143815
Rule of 40 score: 11.93699074812365
Financial ratios for BMEA — annual report dated 2021-12-31
Capital expenditures: 3171000
Buffett classification: The Gruesome
Stock price: 7.45
Shares outstanding: 72299440
Market cap (USD): 538630828
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMEA — annual report dated 2022-12-31
Total revenue: 0
Operating income: -83634000
Net income: -81828000
Capital expenditures: 1030000
Operating cash flow: -62417000
Depreciation & amortization: 691000
Net tangible assets: 108539000
Owner earnings: -82167000
Return on net tangible assets (%): -75.70274279291314
Buffett classification: The Gruesome
Stock price: 8.43
Shares outstanding: 72299440
Book value: 108539000
P/B ratio: 5.615348208478059
Market cap (USD): 609484279.1999999
Debt to equity: 0.021052340633320742
Current ratio: 6.16821108842469
Quick ratio: 6.16821108842469
Free cash flow (dilution-adjusted): -73783000
Buyback yield (%): 0
Retained earnings: -131570000
Capitalized R&D asset: 62713000
ROCI (R&D-adjusted, %): -24.187818188477454
Rule of 40 score: 0
Financial ratios for BMEA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -126135000
Net income: -117255000
Capital expenditures: 3370000
Operating cash flow: -96592000
Depreciation & amortization: 1515000
Net tangible assets: 169237000
Owner earnings: -119110000
Return on net tangible assets (%): -70.38059053280311
Buffett classification: The Gruesome
Stock price: 14.52
Shares outstanding: 72299440
Book value: 169237000
P/B ratio: 6.20306356647778
Market cap (USD): 1049787868.8
Debt to equity: 0.060837760064288544
Current ratio: 7.838188976377952
Quick ratio: 7.838188976377952
Free cash flow (dilution-adjusted): -114093000
Buyback yield (%): 0
Retained earnings: -248825000
Capitalized R&D asset: 144563710
ROCI (R&D-adjusted, %): -24.461387201904117
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2024-09-30
Capital expenditures: 186000
Buffett classification: The Gruesome
Stock price: 10.1
Shares outstanding: 72299440
Market cap (USD): 730224344
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2024-12-31
Capital expenditures: 82000
Buffett classification: The Gruesome
Stock price: 3.88
Shares outstanding: 72299440
Market cap (USD): 280521827.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMEA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -144070000
Net income: -138426000
Capital expenditures: 362000
Operating cash flow: -119894000
Depreciation & amortization: 1748000
Net tangible assets: 51573000
Owner earnings: -137040000
Return on net tangible assets (%): -265.7204351113955
Buffett classification: The Gruesome
Stock price: 3.88
Shares outstanding: 72299440
Book value: 51573000
P/B ratio: 5.4393156729296335
Market cap (USD): 280521827.2
Debt to equity: 0.17006961006728327
Current ratio: 3.152863009274212
Quick ratio: 3.152863009274212
Free cash flow (dilution-adjusted): -139350000
Buyback yield (%): 0
Retained earnings: -387251000
Capitalized R&D asset: 207486110
ROCI (R&D-adjusted, %): -45.317966875096026
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -29712000
Net income: -29262000
Capital expenditures: 0
Operating cash flow: -25667000
Depreciation & amortization: 468000
Net tangible assets: 28737000
Owner earnings: -28794000
Return on net tangible assets (%): -100.19835055851341
Buffett classification: The Gruesome
Stock price: 2.13
Shares outstanding: 72299440
Book value: 28737000
P/B ratio: 5.358868608414239
Market cap (USD): 153997807.2
Debt to equity: 0.2758464697080419
Current ratio: 2.2548821718726346
Quick ratio: 2.2548821718726346
Free cash flow (dilution-adjusted): -28836000
Buyback yield (%): 0
Retained earnings: -416513000
Receivables turnover: 0
Capitalized R&D asset: 22897000
ROCI (R&D-adjusted, %): -24.851351738768955
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -21276000
Net income: -20740000
Capital expenditures: 0
Operating cash flow: -19212000
Depreciation & amortization: 467000
Net tangible assets: 27510000
Owner earnings: -20273000
Return on net tangible assets (%): -73.69320247182843
Buffett classification: The Gruesome
Stock price: 1.8
Shares outstanding: 72299440
Book value: 27510000
P/B ratio: 4.730606761177754
Market cap (USD): 130138992
Debt to equity: 0.256415848782261
Current ratio: 3.680726320582878
Quick ratio: 3.680726320582878
Free cash flow (dilution-adjusted): -21785000
Buyback yield (%): 0
Retained earnings: -437253000
Receivables turnover: 0
Capitalized R&D asset: 31906990
ROCI (R&D-adjusted, %): -20.41591663610546
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -18600000
Net income: -16407000
Capital expenditures: 0
Operating cash flow: -11550000
Depreciation & amortization: 427000
Net tangible assets: 15619000
Owner earnings: -15980000
Return on net tangible assets (%): -102.31128753441321
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 72299440
Book value: 15619000
P/B ratio: 9.350462180677379
Market cap (USD): 146044868.8
Debt to equity: 0.44023304949100456
Current ratio: 3.176357211692901
Quick ratio: 3.176357211692901
Free cash flow (dilution-adjusted): -13490000
Buyback yield (%): 0
Retained earnings: -453660000
Receivables turnover: 0
Capitalized R&D asset: 33056230
ROCI (R&D-adjusted, %): -30.481846718978527
Rule of 40 score: 0
Financial ratios for BMEA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -11719000
Net income: 4612000
Capital expenditures: 0
Operating cash flow: -13942000
Depreciation & amortization: 47000
Net tangible assets: 29552000
Owner earnings: 4659000
Return on net tangible assets (%): 15.765430427720627
Buffett classification: The Gruesome
Stock price: 1.24
P/E ratio: 4.859676149176063
Shares outstanding: 72299440
Book value: 29552000
P/B ratio: 3.033679805089334
Market cap (USD): 89651305.6
Debt to equity: 0.053769626421223606
Current ratio: 5.229258625349067
Quick ratio: 5.229258625349067
Free cash flow (dilution-adjusted): -15780000
Buyback yield (%): 0
Retained earnings: -449048000
Capitalized R&D asset: 23230450
ROCI (R&D-adjusted, %): -23.523327079336187
Rule of 40 score: 0
Financial ratios for BMEA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -81307000
Net income: -61797000
Capital expenditures: 0
Operating cash flow: -70371000
Depreciation & amortization: 1409000
Net tangible assets: 29552000
Owner earnings: -60388000
Return on net tangible assets (%): -204.34488359501896
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 72299440
Book value: 29552000
P/B ratio: 3.033679805089334
Market cap (USD): 89651305.6
Debt to equity: 0.053769626421223606
Current ratio: 5.229258625349067
Quick ratio: 5.229258625349067
Free cash flow (dilution-adjusted): -79891000
Buyback yield (%): 0
Retained earnings: -449048000
Capitalized R&D asset: 174936130
ROCI (R&D-adjusted, %): -51.04662486914575
Rule of 40 score: 0
Financial ratios for BMT.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.102272727272727
Shares outstanding: 2157561765
Market cap (USD): 60632389145.965904
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMT.DE — annual report dated 2022-12-31
Total revenue: 33319277108.433735
Gross profit: 27832530120.48193
Operating income: 17203614457.831326
Net income: 8248192771.084338
Capital expenditures: 592771084.3373494
Operating cash flow: 12522891566.26506
Depreciation & amortization: 1572289156.626506
Net tangible assets: -64707228915.66265
Owner earnings: 9227710843.373495
Return on net tangible assets (%): -14.260710894296835
Capex to operating income (%): 3.445619441137335
Buffett classification: The Great
Stock price: 31.76595744680851
P/E ratio: 8.309337223072799
Shares outstanding: 2157561765
Book value: 91216867469.87952
P/B ratio: 0.7513633949168721
Market cap (USD): 68537015215.85107
Debt to equity: 0.5697926297714966
Current ratio: 0.8631042401837226
Quick ratio: 0.5454545454545454
Effective tax rate (%): 26.576576576576578
Interest coverage ratio: 8.586289837642815
COGS to revenue (%): 16.467184957512202
R&D to revenue (%): 0.4990056047730972
SG&A to revenue (%): 4.299403362863859
Free cash flow (dilution-adjusted): 11732530120.481928
Buyback yield (%): 3.677548430979692
Retained earnings: 61683132530.12048
Inventory turnover: 0.8030329747839887
Receivables turnover: 6.332722692924204
Capitalized R&D asset: 166265060.24096388
ROCI (R&D-adjusted, %): 10.580059043959036
FCF margin (%): 35.212438980292895
Rule of 40 score: 35.212438980292895
Financial ratios for BMT.DE — annual report dated 2023-12-31
Total revenue: 34535443037.974686
Gross profit: 28660759493.670883
Operating income: -10801265822.78481
Net income: -17960759493.670887
Capital expenditures: 513924050.6329114
Operating cash flow: 13562025316.455696
Depreciation & amortization: 30379746835.443035
Net tangible assets: -54425316455.6962
Owner earnings: 11905063291.139236
Buffett classification: The Gruesome
Stock price: 25.31111111111111
Shares outstanding: 2157561765
Book value: 67005063291.13924
P/B ratio: 0.8150172969125704
Market cap (USD): 54610285563
Debt to equity: 0.7505572977670306
Current ratio: 0.9051234607286417
Quick ratio: 0.590059337714541
Interest coverage ratio: -4.52199258081611
COGS to revenue (%): 17.010592676758417
R&D to revenue (%): 0.663416779679654
SG&A to revenue (%): 4.328702855257852
Free cash flow (dilution-adjusted): 12801265822.78481
Buyback yield (%): 0.2549712108142743
Retained earnings: 40034177215.18987
Inventory turnover: 0.9398541919805589
Receivables turnover: 7.534658933996134
Capitalized R&D asset: 340511514.4120787
ROCI (R&D-adjusted, %): -8.185028003110142
Rosenberg metric: 4.981379563382835
FCF margin (%): 37.06703808232232
Revenue growth (%): 3.6500369608352528
Rule of 40 score: 40.71707504315757
Financial ratios for BMT.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -55791250000
Buffett classification: The Gruesome
Stock price: 33.53125
Shares outstanding: 2157561765
Book value: 62493750000
P/B ratio: 1.1576476516876688
Market cap (USD): 72345742932.65625
Debt to equity: 0.7390739073907391
Current ratio: 0.7626313823827562
Quick ratio: 0.5163527717014352
Buyback yield (%): 0
Retained earnings: 32522500000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMT.DE — annual report dated 2024-12-31
Total revenue: 32333750000
Gross profit: 26788750000
Operating income: 13291250000
Net income: 3976250000
Capital expenditures: 426250000
Operating cash flow: 12656250000
Depreciation & amortization: 3827500000
Net tangible assets: -55791250000
Owner earnings: 7377500000
Return on net tangible assets (%): -13.223399726659647
Capex to operating income (%): 3.206997084548105
Buffett classification: The Great
Stock price: 33.53125
P/E ratio: 18.19446537130619
Shares outstanding: 2157561765
Book value: 62493750000
P/B ratio: 1.1576476516876688
Market cap (USD): 72345742932.65625
Debt to equity: 0.7390739073907391
Current ratio: 0.7626313823827562
Quick ratio: 0.5163527717014352
Effective tax rate (%): 10.090446579988695
Interest coverage ratio: 5.83589462129528
COGS to revenue (%): 17.149263540418293
R&D to revenue (%): 0.6726717439208257
SG&A to revenue (%): 4.411025631113001
Free cash flow (dilution-adjusted): 11896250000
Buyback yield (%): 1.3684288250679122
Retained earnings: 32522500000
Inventory turnover: 0.9610051993067591
Receivables turnover: 7.177302996670366
Capitalized R&D asset: 425873798.9934421
ROCI (R&D-adjusted, %): 10.590960405612732
Rosenberg metric: -8.170649171270707
FCF margin (%): 36.792051648818955
Revenue growth (%): -6.375169519481001
Rule of 40 score: 30.416882129337953
Financial ratios for BMT.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -53902739726.0274
Buffett classification: The Gruesome
Stock price: 45.235294117647065
Shares outstanding: 2157561765
Book value: 64626027397.260284
P/B ratio: 1.51019558136885
Market cap (USD): 97597941016.76472
Debt to equity: 0.7462958645102485
Current ratio: 0.8674043510877719
Quick ratio: 0.5493248312078018
Buyback yield (%): 0
Retained earnings: 31498630136.9863
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.3
Shares outstanding: 8813858
Market cap (USD): 839960667.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNR — annual report dated 2022-12-31
Total revenue: 80925000
Gross profit: 54603304.59770115
Operating income: -140863074.71264368
Net income: -139544971.26436782
Capital expenditures: 9752298.850574713
Operating cash flow: -65633333.333333336
Depreciation & amortization: 17829885.057471264
Net tangible assets: 166142959.77011493
Owner earnings: -131467385.05747128
Return on net tangible assets (%): -79.1290736841195
Buffett classification: The Gruesome
Stock price: 22.5
Shares outstanding: 8813858
Book value: 166428304.59770116
P/B ratio: 1.1915749876763404
Market cap (USD): 198311805
Debt to equity: 0.04384460189184359
Current ratio: 3.0593241965628954
Quick ratio: 2.7425890324728823
COGS to revenue (%): 32.526036950631884
R&D to revenue (%): 74.90048611776903
SG&A to revenue (%): 166.6396798511464
Free cash flow (dilution-adjusted): -122710775.86206897
Buyback yield (%): 5.204418875363599
Retained earnings: -459762356.3218391
Inventory turnover: 1.40575195095188
Receivables turnover: 3.308688245315162
Capitalized R&D asset: 60613218.390804596
ROCI (R&D-adjusted, %): -43.75547077676895
FCF margin (%): -151.635187966721
Rule of 40 score: -151.635187966721
Financial ratios for BNR — annual report dated 2023-12-31
Total revenue: 75588607.5949367
Gross profit: 51086779.18424754
Operating income: -94137974.6835443
Net income: -91939381.1533052
Capital expenditures: 1127988.7482419128
Operating cash flow: -35975105.48523206
Depreciation & amortization: 18762306.610407874
Net tangible assets: 107938959.21237692
Owner earnings: -74305063.29113925
Return on net tangible assets (%): -68.8398923181566
Buffett classification: The Gruesome
Stock price: 9.3
Shares outstanding: 8813858
Book value: 108074542.8973277
P/B ratio: 0.7584476159003657
Market cap (USD): 81968879.4
Debt to equity: 0.01603831287984279
Current ratio: 3.3569356480004857
Quick ratio: 3.0948649018089034
COGS to revenue (%): 32.41471061616753
R&D to revenue (%): 64.56892461413939
SG&A to revenue (%): 127.55626261780498
Free cash flow (dilution-adjusted): -73964275.66807313
Buyback yield (%): 1.197154285093262
Retained earnings: -542002109.7046413
Inventory turnover: 2.524022022602144
Receivables turnover: 3.20260172097347
Capitalized R&D asset: 89417607.3766914
ROCI (R&D-adjusted, %): -41.18039487385001
Rosenberg metric: -0.0580158174538887
FCF margin (%): -97.85108896889857
Revenue growth (%): -6.594244553677234
Rule of 40 score: -104.4453335225758
Financial ratios for BNR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.27
Shares outstanding: 8813858
Market cap (USD): 28821315.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNR — annual report dated 2024-12-31
Total revenue: 70660547.94520548
Gross profit: 49643835.61643836
Operating income: -44168767.12328767
Net income: -47483013.69863014
Capital expenditures: 527945.205479452
Operating cash flow: -12638493.150684932
Depreciation & amortization: 7150684.93150685
Net tangible assets: 79507671.23287672
Owner earnings: -40860273.97260274
Return on net tangible assets (%): -51.39161207844164
Buffett classification: The Gruesome
Stock price: 6.75
Shares outstanding: 8813858
Book value: 79565342.46575344
P/B ratio: 0.7477318598308962
Market cap (USD): 59493541.5
Debt to equity: 0.09008017877956774
Current ratio: 2.916338401571166
Quick ratio: 2.7144487962778685
COGS to revenue (%): 29.743205989663103
R&D to revenue (%): 45.032976491890615
SG&A to revenue (%): 87.73220219378003
Free cash flow (dilution-adjusted): -34775342.46575343
Buyback yield (%): 0.016578293122170473
Retained earnings: -575378219.1780822
Inventory turnover: 2.853672600115321
Receivables turnover: 2.9739459316102326
Capitalized R&D asset: 84523433.22092205
ROCI (R&D-adjusted, %): -35.098524307590836
Rosenberg metric: -0.02956442575305826
FCF margin (%): -49.21465156585024
Revenue growth (%): -6.519579876559764
Rule of 40 score: -55.73423144241001
Financial ratios for BNR — quarterly report dated 2024-12-31
Total revenue: 17263287.671232875
Gross profit: 12249589.04109589
Operating income: -6410958.904109589
Net income: -11136164.383561645
Capital expenditures: 0
Operating cash flow: 2611232.8767123288
Net tangible assets: 79507671.23287672
Owner earnings: -11136164.383561645
Return on net tangible assets (%): -14.006402414861322
Buffett classification: The Gruesome
Stock price: 6.75
Shares outstanding: 8813858
Book value: 79565342.46575344
P/B ratio: 0.7477318598308962
Market cap (USD): 59493541.5
Debt to equity: 0.09008017877956774
Current ratio: 2.916338401571166
Quick ratio: 2.7144487962778685
COGS to revenue (%): 29.04254812651759
R&D to revenue (%): 41.42371966799448
SG&A to revenue (%): 66.67010521972354
Free cash flow (dilution-adjusted): 1792465.7534246575
Buyback yield (%): 0
Retained earnings: -575378219.1780822
Inventory turnover: 0.6807655822777747
Receivables turnover: 0.7265735354315727
Capitalized R&D asset: 7151095.890410959
ROCI (R&D-adjusted, %): -1.7875207275230214
FCF margin (%): 10.383107711351986
Rule of 40 score: 10.383107711351986
Financial ratios for BNR — quarterly report dated 2025-03-31
Total revenue: 18330853.99449036
Gross profit: 13416115.70247934
Operating income: -2090771.349862259
Net income: -1859504.132231405
Capital expenditures: 0
Operating cash flow: -3240633.608815427
Net tangible assets: 78707438.01652893
Owner earnings: -1859504.132231405
Return on net tangible assets (%): -2.362551976143475
Buffett classification: The Gruesome
Stock price: 4.5
Shares outstanding: 8813858
Book value: 78760606.06060606
P/B ratio: 0.503581206186757
Market cap (USD): 39662361
Debt to equity: 0.07404311282576835
Current ratio: 3.0165853310728377
Quick ratio: 2.7574311156180187
COGS to revenue (%): 26.811289280293355
R&D to revenue (%): 30.348957785425522
SG&A to revenue (%): 54.245502772726596
Free cash flow (dilution-adjusted): -3240633.608815427
Buyback yield (%): 0
Retained earnings: -580407851.2396694
Inventory turnover: 0.5453808999755442
Receivables turnover: 0.7534037964006092
Capitalized R&D asset: 10354457.38707121
ROCI (R&D-adjusted, %): -0.820539901168867
Rosenberg metric: 0.16312557952798087
FCF margin (%): -17.6785741122015
Revenue growth (%): 6.1840267253175085
Rule of 40 score: -11.49454738688399
Financial ratios for BNR — quarterly report dated 2025-06-30
Total revenue: 20718828.451882847
Gross profit: 15077126.917712692
Operating income: -1603486.750348675
Net income: -1353138.0753138075
Capital expenditures: 0
Operating cash flow: -6185355.648535565
Net tangible assets: 78644769.87447698
Owner earnings: -1353138.0753138075
Return on net tangible assets (%): -1.7205696926490068
Buffett classification: The Gruesome
Stock price: 3.16
Shares outstanding: 8813858
Book value: 78693863.31938633
P/B ratio: 0.3539258349404061
Market cap (USD): 27851791.28
Debt to equity: 0.06934344732248089
Current ratio: 3.219088258426722
Quick ratio: 2.9678835098270118
COGS to revenue (%): 27.229828883772907
R&D to revenue (%): 33.502968617472426
SG&A to revenue (%): 47.006475759656425
Free cash flow (dilution-adjusted): -6185355.648535565
Buyback yield (%): 0
Retained earnings: -589046443.5146444
Inventory turnover: 0.6997232312748659
Receivables turnover: 0.7256306051073641
Capitalized R&D asset: 13028643.742110107
ROCI (R&D-adjusted, %): -1.2647526911016216
Rosenberg metric: 0.2985699428704384
FCF margin (%): -29.853790540813435
Revenue growth (%): 13.027076960572776
Rule of 40 score: -16.826713580240657
Financial ratios for BNR — quarterly report dated 2025-09-30
Total revenue: 18485533.707865167
Gross profit: 13882584.26966292
Operating income: -2265589.887640449
Net income: -2353651.6853932585
Capital expenditures: 0
Operating cash flow: 2302528.0898876404
Net tangible assets: 77143398.8764045
Owner earnings: -2353651.6853932585
Return on net tangible assets (%): -3.0510085369250683
Buffett classification: The Gruesome
Stock price: 8.65
Shares outstanding: 8813858
Book value: 77187780.8988764
P/B ratio: 0.987719439685431
Market cap (USD): 76239871.7
Debt to equity: 0.06037370559539428
Current ratio: 3.144556636836912
Quick ratio: 2.9128840722719387
Interest coverage ratio: -1075.3999999999999
COGS to revenue (%): 24.900278839359657
R&D to revenue (%): 31.50732808071906
SG&A to revenue (%): 55.84840864022126
Free cash flow (dilution-adjusted): 2302528.0898876404
Buyback yield (%): 0
Retained earnings: -595536657.3033708
Inventory turnover: 0.6016816905028548
Receivables turnover: 0.6684798618517953
Capitalized R&D asset: 12310914.52724794
ROCI (R&D-adjusted, %): -2.732424730843489
Rosenberg metric: -0.17208902524647104
FCF margin (%): 12.45583777171642
Revenue growth (%): -10.779059005214776
Rule of 40 score: 1.6767787665016431
Financial ratios for BNR — annual report dated 2025-12-31
Total revenue: 77081142.85714285
Gross profit: 57559142.85714286
Operating income: -7835000
Net income: -7906571.428571428
Capital expenditures: 627285.7142857143
Operating cash flow: -4063285.714285714
Depreciation & amortization: 3108714.285714286
Net tangible assets: 76425714.28571428
Owner earnings: -5425142.857142856
Return on net tangible assets (%): -7.098583124602788
Buffett classification: The Gruesome
Stock price: 20.15
Shares outstanding: 8813858
Book value: 76466285.7142857
P/B ratio: 2.322582260155736
Market cap (USD): 177599238.7
Debt to equity: 0.08055837866921745
Current ratio: 2.9904930803553356
Quick ratio: 2.793811594554981
Interest coverage ratio: -1828.1666666666667
COGS to revenue (%): 25.326557542330164
R&D to revenue (%): 30.85690774842096
SG&A to revenue (%): 53.98114788126799
Free cash flow (dilution-adjusted): -6795428.571428572
Buyback yield (%): 0
Retained earnings: -607943857.1428572
Inventory turnover: 2.813199934123847
Receivables turnover: 2.7993006521366945
Capitalized R&D asset: 61210852.11424608
ROCI (R&D-adjusted, %): -13.173263374748448
Rosenberg metric: 0.24874830107685583
FCF margin (%): -8.815941642202652
Revenue growth (%): 9.086534280651621
Rule of 40 score: 0.27059263844896897
Financial ratios for BNR — quarterly report dated 2025-12-31
Total revenue: 18045000
Gross profit: 14080857.142857144
Operating income: -1719714.2857142857
Net income: -2198000
Capital expenditures: 0
Operating cash flow: 3291285.714285714
Net tangible assets: 76425714.28571428
Owner earnings: -2198000
Return on net tangible assets (%): -2.875995364312685
Buffett classification: The Gruesome
Stock price: 20.15
Shares outstanding: 8813858
Book value: 76466285.7142857
P/B ratio: 2.322582260155736
Market cap (USD): 177599238.7
Debt to equity: 0.08055837866921745
Current ratio: 2.9904930803553356
Quick ratio: 2.793811594554981
Interest coverage ratio: -802.5333333333334
COGS to revenue (%): 21.968095633931046
R&D to revenue (%): 27.602422515140717
SG&A to revenue (%): 59.95962474765467
Free cash flow (dilution-adjusted): 2541428.5714285714
Buyback yield (%): 0
Retained earnings: -607943857.1428572
Inventory turnover: 0.5712491765480896
Receivables turnover: 0.6553273394171756
Capitalized R&D asset: 11173806.093306111
ROCI (R&D-adjusted, %): -2.85148738352053
Rosenberg metric: 0.03404236555361522
FCF margin (%): 14.08383802398765
Revenue growth (%): -2.3831267997295122
Rule of 40 score: 11.700711224258137
Financial ratios for CHSN — annual report dated 2023-12-31
Total revenue: 2426534.739803094
Gross profit: 1145896.6244725739
Operating income: -85865.11954992967
Net income: 4724.050632911392
Capital expenditures: 108793.24894514767
Operating cash flow: -415450.4922644163
Depreciation & amortization: 486751.7580872011
Net tangible assets: 1634930.5203938114
Owner earnings: 382682.5597749648
Return on net tangible assets (%): 23.40665581818038
Buffett classification: The Gruesome
Stock price: 9760
P/E ratio: 4789825.681028939
Shares outstanding: 2318379
Book value: 1689782.8410689165
P/B ratio: 13390.702337636745
Market cap (USD): 22627379040
Debt to equity: 1.3794443081260457
Current ratio: 0.6337595287672922
Quick ratio: 0.58461021208337
Effective tax rate (%): 78.04763274162767
COGS to revenue (%): 52.77641792321673
SG&A to revenue (%): 50.762172237536454
Free cash flow (dilution-adjusted): -712773.1364275668
Buyback yield (%): 0
Retained earnings: -21132.770745428974
Inventory turnover: 12.578082759478109
Receivables turnover: 4.7958271344670305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.575344305674181
FCF margin (%): -29.3741162957925
Revenue growth (%): 27.249746471667276
Rule of 40 score: -2.1243698241252247
Financial ratios for CHSN — annual report dated 2024-12-31
Total revenue: 2496922.8767123288
Gross profit: 985523.0136986302
Operating income: -72550.68493150685
Net income: 103600.68493150685
Capital expenditures: 75034.38356164384
Operating cash flow: 484662.7397260274
Depreciation & amortization: 474378.4931506849
Net tangible assets: 2488074.794520548
Owner earnings: 502944.7945205479
Return on net tangible assets (%): 20.214215249002006
Buffett classification: The Gruesome
Stock price: 40880
P/E ratio: 914813.7735060196
Shares outstanding: 2318379
Book value: 2524033.698630137
P/B ratio: 37549.15537436652
Market cap (USD): 94775333520
Debt to equity: 0.7077451476615546
Current ratio: 1.3030601487708926
Quick ratio: 1.2508220483104127
Effective tax rate (%): 8.9788166650419
Interest coverage ratio: -10.399387370405279
COGS to revenue (%): 60.53049844309739
SG&A to revenue (%): 42.37510531455786
Free cash flow (dilution-adjusted): 404756.8493150685
Buyback yield (%): 0
Retained earnings: 53607.94520547945
Inventory turnover: 14.934518451540596
Receivables turnover: 4.5684240892494445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9165925082663502
FCF margin (%): 16.21022631856405
Revenue growth (%): 2.9007677390576565
Rule of 40 score: 19.110994057621706
Financial ratios for CHSN — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2488074.794520548
Buffett classification: The Gruesome
Stock price: 40880
Shares outstanding: 2318379
Book value: 2524033.698630137
P/B ratio: 37549.15537436652
Market cap (USD): 94775333520
Debt to equity: 0.7077451476615546
Current ratio: 1.3030601487708926
Quick ratio: 1.2508220483104127
Buyback yield (%): 0
Retained earnings: 53607.94520547945
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHSN — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3389090.6555090654
Buffett classification: The Gruesome
Stock price: 1040
Shares outstanding: 2318379
Book value: 3423173.6401673635
P/B ratio: 704.3505277407188
Market cap (USD): 2411114160
Debt to equity: 0.6616662500705363
Current ratio: 2.001574469033815
Quick ratio: 1.9496964065239701
Buyback yield (%): 0
Retained earnings: -91695.2580195258
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNX.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.10227272727273
Shares outstanding: 663280832
Market cap (USD): 37874842963.63636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNX.MC — annual report dated 2022-12-31
Total revenue: 3455013829.7872343
Operating income: 245017021.27659577
Net income: -316019148.9361702
Capital expenditures: 2732463829.7872343
Operating cash flow: 1945895744.6808512
Depreciation & amortization: 2468823404.255319
Net tangible assets: -13222938297.872341
Owner earnings: -579659574.4680853
Capex to operating income (%): 1115.2138800604387
Buffett classification: The Gruesome
Stock price: 32.308510638297875
Shares outstanding: 663280832
Book value: 16158936170.212769
P/B ratio: 1.3261773913281631
Market cap (USD): 21429615816.851067
Debt to equity: 1.3739478188736882
Current ratio: 0.9811479243373155
Quick ratio: 0.9790408834820981
Interest coverage ratio: 0.3585834524376687
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -786568085.106383
Buyback yield (%): 1.60305591262221
Retained earnings: -316019148.9361702
Inventory turnover: 0
Receivables turnover: 4.043542894849879
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5518914579918648
FCF margin (%): -22.76598948244503
Rule of 40 score: -22.76598948244503
Financial ratios for CLNX.MC — annual report dated 2023-12-31
Total revenue: 4226751111.111111
Operating income: 341661111.1111111
Net income: -330244444.4444444
Capital expenditures: 2437531111.111111
Operating cash flow: 2297527777.7777777
Depreciation & amortization: 2910235555.5555553
Net tangible assets: -11958810000
Owner earnings: 142459999.99999952
Capex to operating income (%): 713.4353404120392
Buffett classification: The Gruesome
Stock price: 38.988888888888894
Shares outstanding: 663280832
Book value: 16829770000.000004
P/B ratio: 1.5365975091149655
Market cap (USD): 25860582660.977783
Debt to equity: 1.4200978385325524
Current ratio: 0.7662343559589837
Quick ratio: 0.7643012366959043
Interest coverage ratio: 0.40563251339268636
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -140003333.33333334
Buyback yield (%): 0.8580583500298401
Retained earnings: -330244444.4444444
Inventory turnover: 0
Receivables turnover: 4.760039491021298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7476538665676068
FCF margin (%): -3.3123155268191278
Revenue growth (%): 22.33673494069347
Rule of 40 score: 19.024419413874345
Financial ratios for CLNX.MC — quarterly report dated 2024-09-30
Gross profit: 1004444444.4444444
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.84444444444444
Shares outstanding: 663280832
Market cap (USD): 26428056261.68889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNX.MC — annual report dated 2024-12-31
Total revenue: 4239796875
Operating income: 608086458.3333334
Net income: -29211458.333333336
Capital expenditures: 2114933333.3333335
Operating cash flow: 2402680208.3333335
Depreciation & amortization: 2717017708.3333335
Net tangible assets: -9122968750
Owner earnings: 572872916.6666665
Capex to operating income (%): 347.8014194116448
Buffett classification: The Gruesome
Stock price: 31.333333333333332
Shares outstanding: 663280832
Book value: 15962836458.333336
P/B ratio: 1.3019490274748187
Market cap (USD): 20782799402.666664
Debt to equity: 1.399070092688597
Current ratio: 0.6302372214679284
Quick ratio: 0.6281861419368413
Interest coverage ratio: 0.7149901465222551
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 287746875
Buyback yield (%): 0
Retained earnings: -29211458.333333336
Inventory turnover: 0
Receivables turnover: 4.809070608251807
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4552885241257407
FCF margin (%): 6.786808035467501
Revenue growth (%): 0.3086475533086077
Rule of 40 score: 7.095455588776108
Financial ratios for CLNX.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.333333333333332
Shares outstanding: 663280832
Market cap (USD): 20782799402.666664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNX.MC — quarterly report dated 2025-03-31
Total revenue: 1047826086.9565217
Gross profit: 968478260.8695651
Operating income: 161956521.73913044
Net income: -53260869.56521739
Capital expenditures: 0
Depreciation & amortization: 704347826.0869565
Net tangible assets: -9586956521.73913
Owner earnings: 651086956.5217391
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 35.17391304347826
Shares outstanding: 663280832
Book value: 16373913043.47826
P/B ratio: 1.424838537142857
Market cap (USD): 23330182308.173912
Debt to equity: 1.4228624535315986
Current ratio: 0.7315250484362026
Quick ratio: 0.7293108220315527
COGS to revenue (%): 7.572614107883817
Buyback yield (%): 0
Retained earnings: -53260869.56521739
Inventory turnover: 9.125
Receivables turnover: 0.7980132450331127
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.37869160778732275
Rule of 40 score: 0
Financial ratios for CLNX.MC — quarterly report dated 2025-06-30
Total revenue: 1223723529.4117646
Operating income: 44198823.52941176
Net income: -77696470.58823529
Capital expenditures: 0
Depreciation & amortization: 793812941.1764706
Net tangible assets: -10771578823.529411
Owner earnings: 716116470.5882354
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 38.23529411764706
Shares outstanding: 663280832
Book value: 16809950588.235298
P/B ratio: 1.508674136845277
Market cap (USD): 25360737694.117645
Debt to equity: 1.5323082448784884
Current ratio: 0.699233961933548
Quick ratio: 0.6969947105591695
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -135343529.4117647
Inventory turnover: 0
Receivables turnover: 1.3341486595856842
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.09634859619154147
Revenue growth (%): 16.78689284842567
Rule of 40 score: 16.78689284842567
Financial ratios for CLNX.MC — quarterly report dated 2025-09-30
Total revenue: 1170588235.2941177
Gross profit: 1083529411.764706
Operating income: 203529411.7647059
Net income: -174117647.05882353
Capital expenditures: 0
Depreciation & amortization: 769411764.7058824
Net tangible assets: -10654117647.058825
Owner earnings: 595294117.647059
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.22352941176471
Shares outstanding: 663280832
Book value: 16474117647.058823
P/B ratio: 1.3779075485881598
Market cap (USD): 22699811062.211765
Debt to equity: 1.563450689138042
Current ratio: 0.7209758833426808
Quick ratio: 0.7184520471116096
COGS to revenue (%): 7.4371859296482405
Buyback yield (%): 0
Retained earnings: -309411764.7058824
Inventory turnover: 8.222222222222221
Receivables turnover: 0.8043654001616815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.44589927315841027
Revenue growth (%): -4.34209957074117
Rule of 40 score: -4.34209957074117
Financial ratios for CLNX.MC — annual report dated 2025-12-31
Total revenue: 4847361176.470589
Operating income: 637549411.7647059
Net income: -414910588.2352941
Capital expenditures: 2070851764.7058823
Operating cash flow: 2689465882.352941
Depreciation & amortization: 3144571764.7058825
Net tangible assets: -11232138823.529411
Owner earnings: 658809411.7647064
Capex to operating income (%): 324.81431658353586
Buffett classification: The Gruesome
Stock price: 31.83529411764706
Shares outstanding: 663280832
Book value: 15675060000
P/B ratio: 1.3470915179474687
Market cap (USD): 21115740369.317646
Debt to equity: 1.642884939515383
Current ratio: 0.510180219213537
Quick ratio: 0.5087724988433887
Interest coverage ratio: 0.7065650204570167
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 618614117.6470588
Buyback yield (%): 5.57351158287683
Retained earnings: -424442352.9411765
Inventory turnover: 0
Receivables turnover: 5.881418304058925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4582830177788428
FCF margin (%): 12.761873834569057
Revenue growth (%): 14.330033239401091
Rule of 40 score: 27.091907073970148
Financial ratios for CLNX.MC — quarterly report dated 2025-12-31
Total revenue: 1392067058.8235295
Operating income: 105784705.88235295
Net income: -90204705.88235295
Capital expenditures: 0
Depreciation & amortization: 819865882.3529412
Net tangible assets: -11232138823.529411
Owner earnings: 729661176.4705882
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 31.83529411764706
Shares outstanding: 663280832
Book value: 15675060000
P/B ratio: 1.3470915179474687
Market cap (USD): 21115740369.317646
Debt to equity: 1.642884939515383
Current ratio: 0.510180219213537
Quick ratio: 0.5087724988433887
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -424442352.9411765
Inventory turnover: 0
Receivables turnover: 1.6890279849547858
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.24196405373815588
Revenue growth (%): 18.92030150753769
Rule of 40 score: 18.92030150753769
Financial ratios for CNNE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.67
Shares outstanding: 43940506
Market cap (USD): 1435536331.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNNE — annual report dated 2022-12-31
Total revenue: 662100000
Gross profit: 31200000
Operating income: -144600000
Net income: -428100000
Capital expenditures: 5100000
Operating cash flow: -205100000
Depreciation & amortization: 44600000
Net tangible assets: 2641900000
Owner earnings: -388600000
Return on net tangible assets (%): -14.709110867178923
Buffett classification: The Gruesome
Stock price: 19.2
Shares outstanding: 43940506
Book value: 2714900000
P/B ratio: 0.3107509356514052
Market cap (USD): 843657715.1999999
Debt to equity: 0.11050130759880658
Current ratio: 2.5313773431132844
Quick ratio: 2.5313773431132844
Interest coverage ratio: -11.75609756097561
COGS to revenue (%): 95.28772088808337
Free cash flow (dilution-adjusted): -220900000
Buyback yield (%): 27.202975313939266
Retained earnings: 1214700000
Receivables turnover: 348.4736842105263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.815505528173705
FCF margin (%): -33.36354025071741
Rule of 40 score: -33.36354025071741
Financial ratios for CNNE — annual report dated 2023-12-31
Total revenue: 570000000
Gross profit: 43000000
Operating income: -118900000
Net income: -313400000
Capital expenditures: 2700000
Operating cash flow: -87800000
Depreciation & amortization: 38300000
Net tangible assets: 2254300000
Owner earnings: -277800000
Return on net tangible assets (%): -12.323115823093643
Buffett classification: The Gruesome
Stock price: 18.14
Shares outstanding: 43940506
Book value: 2309200000
P/B ratio: 0.3451761557422484
Market cap (USD): 797080778.84
Debt to equity: 0.11874242161787632
Current ratio: 1.6493023255813954
Quick ratio: 1.6493023255813954
Interest coverage ratio: -6.64245810055866
COGS to revenue (%): 92.45614035087719
Free cash flow (dilution-adjusted): -101300000
Buyback yield (%): 14.226914386899681
Retained earnings: 901300000
Receivables turnover: 21.923076923076923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.609956575682382
FCF margin (%): -17.771929824561404
Revenue growth (%): -13.910285455369278
Rule of 40 score: -31.68221527993068
Financial ratios for CNNE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.95
Shares outstanding: 43940506
Market cap (USD): 788732082.6999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNNE — annual report dated 2024-12-31
Total revenue: 452500000
Gross profit: 2900000
Operating income: -103700000
Net income: -304600000
Capital expenditures: 200000
Operating cash flow: -90100000
Depreciation & amortization: 27800000
Net tangible assets: 1768000000
Owner earnings: -277000000
Return on net tangible assets (%): -15.667420814479637
Buffett classification: The Gruesome
Stock price: 18.81
Shares outstanding: 43940506
Book value: 1815300000
P/B ratio: 0.45530816826970744
Market cap (USD): 826520917.8599999
Debt to equity: 0.18184322150608714
Current ratio: 1.3440273037542663
Quick ratio: 1.3440273037542663
Interest coverage ratio: -8.939655172413794
COGS to revenue (%): 99.35911602209944
Free cash flow (dilution-adjusted): -116100000
Buyback yield (%): 28.432432249682694
Retained earnings: 567100000
Receivables turnover: 12.675070028011204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.979830964271994
FCF margin (%): -25.65745856353591
Revenue growth (%): -20.614035087719298
Rule of 40 score: -46.27149365125521
Financial ratios for CNNE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.81
Shares outstanding: 43940506
Market cap (USD): 826520917.8599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNNE — quarterly report dated 2025-03-31
Total revenue: 103200000
Gross profit: -2000000
Operating income: -21400000
Net income: -113000000
Capital expenditures: 200000
Operating cash flow: 9100000
Depreciation & amortization: 6500000
Net tangible assets: 1651900000
Owner earnings: -106700000
Return on net tangible assets (%): -6.459228766874508
Buffett classification: The Gruesome
Stock price: 17.49
Shares outstanding: 43940506
Book value: 1696700000
P/B ratio: 0.45294951962043967
Market cap (USD): 768519449.9399999
Debt to equity: 0.18771733364766902
Current ratio: 4.190140845070423
Quick ratio: 4.190140845070423
Interest coverage ratio: -5.631578947368421
COGS to revenue (%): 101.93798449612403
Free cash flow (dilution-adjusted): 3500000
Buyback yield (%): 0
Retained earnings: 446500000
Receivables turnover: 9.82857142857143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1193639502039963
FCF margin (%): 3.391472868217054
Rule of 40 score: 3.391472868217054